Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 48 Lymphoma 34 Lymphoma, Large B-Cell, Diffuse 32 Lymphoma, Non-Hodgkin 23 Osteosarcoma 21 Hodgkin Disease 17 Testicular Neoplasms 16 Burkitt Lymphoma 13 Testicular Germ Cell Tumor 12 Precursor Cell Lymphoblastic Leukemia-Lymphoma 12 Ovarian Neoplasms 12 Teratoma 9 Neuroectodermal Tumors, Primitive, Peripheral 9 Lymphoma, Large-Cell, Immunoblastic 9 Lymphoma, Follicular 9 Neuroblastoma 8 Lymphoma, Large-Cell, Anaplastic 8 Central Nervous System Neoplasms 8 Recurrence 7 Lymphoma, Mantle-Cell 7 Lymphoma, B-Cell 7 Leukemia 7 Endodermal Sinus Tumor 7 Seminoma 6 Rhabdomyosarcoma 6 Lymphoma, B-Cell, Marginal Zone 6 Breast Neoplasms 6 Small Cell Lung Carcinoma 5 Neoplasms, Germ Cell and Embryonal 5 Neoplasms 5

Interventions

selinexor 1 pegfilgrastim 1 midostaurin 1 Topotecan 1 Rituximab 1 Prednisone 1 Positron Emission Tomography Computed Tomography 1 Paclitaxel 1 Methylprednisolone 1 Immunologic Techniques 1 Ifosfamide 1 Flow Cytometry 1 Etoposide 1 Dexamethasone 1 Clofarabine 1 Carboplatin 1 Bexarotene 1 Alemtuzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Aggression × Ifosfamide × Clear all

NCT02471911 2022-04-12

KPT-330+RICE

Weill Medical College of Cornell University

Phase 1 Completed

Aggression, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon ⚡